RAC 2.20% $1.78 race oncology ltd

Ann: Updated Strategy and Investor Presentation, page-436

  1. 19,271 Posts.
    lightbulb Created with Sketch. 6368
    Thanks for the very kind words. Even if RAC is not the company for many people reading my posts, I hope they at least get a better understanding of how the biotech sector works. As I have said many time before, Australia has all the factors required to become a biotech powerhouse (good scientists, good regulatory environment, excellent government support) except for informed and educated investors. This last hurdle can be solved.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.